Skip to main content
Top
Published in: Endocrine 2/2012

01-10-2012 | Original Article

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women

Authors: Seong-Su Moon, Young-Sil Lee, Sung Woo Kim

Published in: Endocrine | Issue 2/2012

Login to get access

Abstract

Osteoporosis is a disease associated with insulin resistant states such as central obesity, diabetes, and metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) is also increased in such conditions. However, little is known about whether osteoporosis and nonalcoholic fatty liver disease are etiologically related to each other or not. We examined whether bone mineral density (BMD) is associated with NAFLD in pre- and postmenopausal women. Four hundred eighty-one female subjects (216 premenopausal and 265 postmenopausal) were enrolled. Lumbar BMD was measured using dual-energy X-ray absorptiometry. Liver ultrasonography was done to check the severity of fatty liver. We excluded subjects with a secondary cause of liver disease. Blood pressure, lipid profile, fasting plasma glucose, alanine aminotransferase (ALT), aspartate aminotransferase, and body mass index were measured in every subject. Mean lumbar BMD was lower in subjects with NAFLD than those without NAFLD in postmenopausal women (0.98 ± 0.01 vs. 1.01 ± 0.02 g/cm2, P = 0.046). Multiple correlation analysis revealed a significant association between mean lumbar BMD and NAFLD in postmenopausal subjects after adjusting for age, body mass index, ALT, smoking status, and alcohol consumption (β coefficient −0.066, 95% CI −0.105 to −0.027, P = 0.001). Even after adjusting the presence of metabolic syndrome, the significance was maintained (β coefficient −0.043, 95% CI −0.082 to −0.004, P = 0.031). Lumbar BMD is related with NAFLD in postmenopausal females. We suggest that postmenopausal women with NAFLD may have a higher risk of osteoporosis than those without.
Literature
1.
go back to reference Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94(6), 646–650 (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94(6), 646–650 (1993)
2.
go back to reference C. Cooper, E.J. Atkinson, S.J. Jacobsen, W.M. O’Fallon, L.J. Melton 3rd, Population-based study of survival after osteoporotic fractures. Am. J. Epidemiol. 137(9), 1001–1005 (1993)PubMed C. Cooper, E.J. Atkinson, S.J. Jacobsen, W.M. O’Fallon, L.J. Melton 3rd, Population-based study of survival after osteoporotic fractures. Am. J. Epidemiol. 137(9), 1001–1005 (1993)PubMed
3.
go back to reference M.A. Petit, M.L. Paudel, B.C. Taylor, J.M. Hughes, E.S. Strotmeyer, A.V. Schwartz, J.A. Cauley, J.M. Zmuda, A.R. Hoffman, K.E. Ensrud, Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J. Bone Miner. Res. 25(2), 285–291 (2010) M.A. Petit, M.L. Paudel, B.C. Taylor, J.M. Hughes, E.S. Strotmeyer, A.V. Schwartz, J.A. Cauley, J.M. Zmuda, A.R. Hoffman, K.E. Ensrud, Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J. Bone Miner. Res. 25(2), 285–291 (2010)
4.
go back to reference D. von Muhlen, S. Safii, S.K. Jassal, J. Svartberg, E. Barrett-Connor, Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos. Int. 18(10), 1337–1344 (2007)CrossRef D. von Muhlen, S. Safii, S.K. Jassal, J. Svartberg, E. Barrett-Connor, Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos. Int. 18(10), 1337–1344 (2007)CrossRef
5.
go back to reference D.K. Hwang, H.J. Choi, The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos. Int. 21(3), 425–431 (2010) D.K. Hwang, H.J. Choi, The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos. Int. 21(3), 425–431 (2010)
6.
go back to reference Kim, K.C., Shin, D.H., Lee, S.Y., Im, J.A., Lee, D.C.: Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J 51(6), 857–863 (2010) Kim, K.C., Shin, D.H., Lee, S.Y., Im, J.A., Lee, D.C.: Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J 51(6), 857–863 (2010)
7.
go back to reference Y.K. Jeon, J.G. Lee, S.S. Kim, B.H. Kim, S.J. Kim, Y.K. Kim, I.J. Kim, Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr. J. 58(2), 87–93 (2011) Y.K. Jeon, J.G. Lee, S.S. Kim, B.H. Kim, S.J. Kim, Y.K. Kim, I.J. Kim, Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr. J. 58(2), 87–93 (2011)
8.
go back to reference M.A. Cornier, D. Dabelea, T.L. Hernandez, R.C. Lindstrom, A.J. Steig, N.R. Stob, R.E. Van Pelt, H. Wang, R.H. Eckel, The metabolic syndrome. Endocr. Rev. 29(7), 777–822 (2008)PubMedCrossRef M.A. Cornier, D. Dabelea, T.L. Hernandez, R.C. Lindstrom, A.J. Steig, N.R. Stob, R.E. Van Pelt, H. Wang, R.H. Eckel, The metabolic syndrome. Endocr. Rev. 29(7), 777–822 (2008)PubMedCrossRef
9.
go back to reference G.A. Bray, T. Bellanger, Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29(1), 109–117 (2006)PubMedCrossRef G.A. Bray, T. Bellanger, Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29(1), 109–117 (2006)PubMedCrossRef
10.
go back to reference Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106(25), 3143–3421 (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106(25), 3143–3421 (2002)
11.
go back to reference A.I. Shulman, D.J. Mangelsdorf, Retinoid x receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 353(6), 604–615 (2005)PubMedCrossRef A.I. Shulman, D.J. Mangelsdorf, Retinoid x receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 353(6), 604–615 (2005)PubMedCrossRef
12.
go back to reference E. Scorletti, P.C. Calder, C.D. Byrne, Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 40(3), 332–343 (2011) E. Scorletti, P.C. Calder, C.D. Byrne, Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 40(3), 332–343 (2011)
14.
go back to reference G. Targher, L. Bertolini, R. Padovani, S. Rodella, R. Tessari, L. Zenari, C. Day, G. Arcaro, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30(5), 1212–1218 (2007)PubMedCrossRef G. Targher, L. Bertolini, R. Padovani, S. Rodella, R. Tessari, L. Zenari, C. Day, G. Arcaro, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30(5), 1212–1218 (2007)PubMedCrossRef
15.
go back to reference S. Bellentani, G. Saccoccio, F. Masutti, L.S. Croce, G. Brandi, F. Sasso, G. Cristanini, C. Tiribelli, Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132(2), 112–117 (2000)PubMed S. Bellentani, G. Saccoccio, F. Masutti, L.S. Croce, G. Brandi, F. Sasso, G. Cristanini, C. Tiribelli, Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132(2), 112–117 (2000)PubMed
16.
go back to reference J.R. Lewis, S.R. Mohanty, Nonalcoholic fatty liver disease: a review and update. Dig. Dis. Sci. 55(3), 560–578 (2010) J.R. Lewis, S.R. Mohanty, Nonalcoholic fatty liver disease: a review and update. Dig. Dis. Sci. 55(3), 560–578 (2010)
17.
go back to reference M. Lazo, J.M. Clark, The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28(4), 339–350 (2008)PubMedCrossRef M. Lazo, J.M. Clark, The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28(4), 339–350 (2008)PubMedCrossRef
18.
go back to reference C. Loguercio, T. De Simone, M.V. D’Auria, I. de Sio, A. Federico, C. Tuccillo, A.M. Abbatecola, C. Del Vecchio Blanco, Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig. Liver Dis. 36(6), 398–405 (2004). doi:10.1016/j.dld.2004.01.022 C. Loguercio, T. De Simone, M.V. D’Auria, I. de Sio, A. Federico, C. Tuccillo, A.M. Abbatecola, C. Del Vecchio Blanco, Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig. Liver Dis. 36(6), 398–405 (2004). doi:10.​1016/​j.​dld.​2004.​01.​022
19.
go back to reference C. Loguercio, V. De Girolamo, I. de Sio, C. Tuccillo, A. Ascione, F. Baldi, G. Budillon, L. Cimino, A. Di Carlo, M.P. Di Marino, F. Morisco, F. Picciotto, L. Terracciano, R. Vecchione, V. Verde, C. Del Vecchio Blanco, Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J. Hepatol. 35(5), 568–574 (2001)PubMedCrossRef C. Loguercio, V. De Girolamo, I. de Sio, C. Tuccillo, A. Ascione, F. Baldi, G. Budillon, L. Cimino, A. Di Carlo, M.P. Di Marino, F. Morisco, F. Picciotto, L. Terracciano, R. Vecchione, V. Verde, C. Del Vecchio Blanco, Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J. Hepatol. 35(5), 568–574 (2001)PubMedCrossRef
20.
go back to reference World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communication, Sydney (2000) World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communication, Sydney (2000)
21.
go back to reference A.J. Sanyal, AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123(5), 1705–1725 (2002)PubMedCrossRef A.J. Sanyal, AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123(5), 1705–1725 (2002)PubMedCrossRef
22.
go back to reference D. Joy, V.R. Thava, B.B. Scott, Diagnosis of fatty liver disease: Is biopsy necessary? Eur. J. Gastroenterol. Hepatol. 15(5), 539–543 (2003)PubMed D. Joy, V.R. Thava, B.B. Scott, Diagnosis of fatty liver disease: Is biopsy necessary? Eur. J. Gastroenterol. Hepatol. 15(5), 539–543 (2003)PubMed
23.
go back to reference S.H. Park, W.K. Jeon, S.H. Kim, H.J. Kim, D.I. Park, Y.K. Cho, I.K. Sung, C.I. Sohn, D.K. Keum, B.I. Kim, Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21(1 Pt 1), 138–143 (2006)PubMedCrossRef S.H. Park, W.K. Jeon, S.H. Kim, H.J. Kim, D.I. Park, Y.K. Cho, I.K. Sung, C.I. Sohn, D.K. Keum, B.I. Kim, Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21(1 Pt 1), 138–143 (2006)PubMedCrossRef
24.
go back to reference J.M. Clark, F.L. Brancati, A.M. Diehl, Nonalcoholic fatty liver disease. Gastroenterology 122(6), 1649–1657 (2002)PubMedCrossRef J.M. Clark, F.L. Brancati, A.M. Diehl, Nonalcoholic fatty liver disease. Gastroenterology 122(6), 1649–1657 (2002)PubMedCrossRef
25.
go back to reference A. Suzuki, M.F. Abdelmalek, Nonalcoholic fatty liver disease in women. Womens Health (Lond. Engl.) 5(2), 191–203 (2009)CrossRef A. Suzuki, M.F. Abdelmalek, Nonalcoholic fatty liver disease in women. Womens Health (Lond. Engl.) 5(2), 191–203 (2009)CrossRef
26.
go back to reference Y.H. Hsu, S.A. Venners, H.A. Terwedow, Y. Feng, T. Niu, Z. Li, N. Laird, J.D. Brain, S.R. Cummings, M.L. Bouxsein, C.J. Rosen, X. Xu, Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am. J. Clin. Nutr. 83(1), 146–154 (2006) Y.H. Hsu, S.A. Venners, H.A. Terwedow, Y. Feng, T. Niu, Z. Li, N. Laird, J.D. Brain, S.R. Cummings, M.L. Bouxsein, C.J. Rosen, X. Xu, Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am. J. Clin. Nutr. 83(1), 146–154 (2006)
27.
go back to reference L.J. Zhao, Y.J. Liu, P.Y. Liu, J. Hamilton, R.R. Recker, H.W. Deng, Relationship of obesity with osteoporosis. J. Clin. Endocrinol. Metab. 92(5), 1640–1646 (2007). doi:10.1210/jc.2006-0572 L.J. Zhao, Y.J. Liu, P.Y. Liu, J. Hamilton, R.R. Recker, H.W. Deng, Relationship of obesity with osteoporosis. J. Clin. Endocrinol. Metab. 92(5), 1640–1646 (2007). doi:10.​1210/​jc.​2006-0572
28.
go back to reference W.Y. Lee, J.S. Park, S.Y. Noh, E.J. Rhee, K.C. Sung, B.S. Kim, J.H. Kang, S.W. Kim, M.H. Lee, J.R. Park, C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int. J. Cardiol. 97(1), 101–106 (2004)PubMedCrossRef W.Y. Lee, J.S. Park, S.Y. Noh, E.J. Rhee, K.C. Sung, B.S. Kim, J.H. Kang, S.W. Kim, M.H. Lee, J.R. Park, C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int. J. Cardiol. 97(1), 101–106 (2004)PubMedCrossRef
29.
go back to reference D.H. Jones, Y.Y. Kong, J.M. Penninger, Role of RANKL and RANK in bone loss and arthritis. Ann. Rheum. Dis. 61(Suppl 2), ii32–39 (2002) D.H. Jones, Y.Y. Kong, J.M. Penninger, Role of RANKL and RANK in bone loss and arthritis. Ann. Rheum. Dis. 61(Suppl 2), ii32–39 (2002)
30.
go back to reference L.C. Hofbauer, M. Schoppet, Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292(4), 490–495 (2004)PubMedCrossRef L.C. Hofbauer, M. Schoppet, Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292(4), 490–495 (2004)PubMedCrossRef
31.
go back to reference M. Krawczyk, L. Bonfrate, P. Portincasa, Nonalcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol. 24(5), 695–708 (2010) M. Krawczyk, L. Bonfrate, P. Portincasa, Nonalcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol. 24(5), 695–708 (2010)
32.
go back to reference P. Trayhurn, I.S. Wood, Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 33(Pt 5), 1078–1081 (2005)PubMed P. Trayhurn, I.S. Wood, Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 33(Pt 5), 1078–1081 (2005)PubMed
33.
go back to reference P. Trayhurn, Adipose tissue in obesity—an inflammatory issue. Endocrinology 146(3), 1003–1005 (2005)PubMedCrossRef P. Trayhurn, Adipose tissue in obesity—an inflammatory issue. Endocrinology 146(3), 1003–1005 (2005)PubMedCrossRef
34.
go back to reference T. Diamond, D. Stiel, M. Lunzer, M. Wilkinson, J. Roche, S. Posen, Osteoporosis and skeletal fractures in chronic liver disease. Gut 31(1), 82–87 (1990)PubMedCrossRef T. Diamond, D. Stiel, M. Lunzer, M. Wilkinson, J. Roche, S. Posen, Osteoporosis and skeletal fractures in chronic liver disease. Gut 31(1), 82–87 (1990)PubMedCrossRef
35.
go back to reference P. Angulo, T.M. Therneau, A. Jorgensen, C.K. DeSotel, K.S. Egan, E.R. Dickson, J.E. Hay, K.D. Lindor, Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J. Hepatol. 29(5), 729–735 (1998)PubMedCrossRef P. Angulo, T.M. Therneau, A. Jorgensen, C.K. DeSotel, K.S. Egan, E.R. Dickson, J.E. Hay, K.D. Lindor, Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J. Hepatol. 29(5), 729–735 (1998)PubMedCrossRef
36.
go back to reference S.P. Pereira, G.P. Bray, P.I. Pitt, F. Li, C. Moniz, R. Williams, Non-invasive assessment of bone density in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 11(3), 323–328 (1999)PubMedCrossRef S.P. Pereira, G.P. Bray, P.I. Pitt, F. Li, C. Moniz, R. Williams, Non-invasive assessment of bone density in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 11(3), 323–328 (1999)PubMedCrossRef
37.
go back to reference J. Newton, R. Francis, M. Prince, O. James, M. Bassendine, D. Rawlings, D. Jones, Osteoporosis in primary biliary cirrhosis revisited. Gut 49(2), 282–287 (2001)PubMedCrossRef J. Newton, R. Francis, M. Prince, O. James, M. Bassendine, D. Rawlings, D. Jones, Osteoporosis in primary biliary cirrhosis revisited. Gut 49(2), 282–287 (2001)PubMedCrossRef
38.
go back to reference G.W. McCaughan, R.B. Feller, Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig. Dis. 12(4), 223–231 (1994)PubMedCrossRef G.W. McCaughan, R.B. Feller, Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig. Dis. 12(4), 223–231 (1994)PubMedCrossRef
39.
go back to reference C.H. Janes, E.R. Dickson, R. Okazaki, S. Bonde, A.F. McDonagh, B.L. Riggs, Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95(6), 2581–2586 (1995)PubMedCrossRef C.H. Janes, E.R. Dickson, R. Okazaki, S. Bonde, A.F. McDonagh, B.L. Riggs, Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95(6), 2581–2586 (1995)PubMedCrossRef
40.
go back to reference F.J. Gallego-Rojo, J.L. Gonzalez-Calvin, M. Munoz-Torres, J.L. Mundi, R. Fernandez-Perez, D. Rodrigo-Moreno, Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28(3), 695–699 (1998)PubMedCrossRef F.J. Gallego-Rojo, J.L. Gonzalez-Calvin, M. Munoz-Torres, J.L. Mundi, R. Fernandez-Perez, D. Rodrigo-Moreno, Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28(3), 695–699 (1998)PubMedCrossRef
41.
go back to reference J.A. Cuthbert, C.Y. Pak, J.E. Zerwekh, K.D. Glass, B. Combes, Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4(1), 1–8 (1984)PubMedCrossRef J.A. Cuthbert, C.Y. Pak, J.E. Zerwekh, K.D. Glass, B. Combes, Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4(1), 1–8 (1984)PubMedCrossRef
42.
go back to reference G. Mazziotti, M. Gola, A. Bianchi, T. Porcelli, A. Giampietro, V. Cimino, M. Doga, C. Gazzaruso, L. De Marinis, A. Giustina, Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40(1), 102–108 (2011) G. Mazziotti, M. Gola, A. Bianchi, T. Porcelli, A. Giampietro, V. Cimino, M. Doga, C. Gazzaruso, L. De Marinis, A. Giustina, Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40(1), 102–108 (2011)
43.
go back to reference G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58–69 (2012) G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58–69 (2012)
Metadata
Title
Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women
Authors
Seong-Su Moon
Young-Sil Lee
Sung Woo Kim
Publication date
01-10-2012
Publisher
Springer US
Published in
Endocrine / Issue 2/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9639-6

Other articles of this Issue 2/2012

Endocrine 2/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.